Moreover, precision medicine approaches for ALS are likely to be particularly useful given its clinical heterogeneity, with a clear role for genetics in this capacity building on the success of SOD1-guided therapeutics. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.